TORONTO--(BUSINESS WIRE)--Sorin Group, (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the Health Canada Therapeutic Products Directorate (TPD) approval to market the REPLY™ family of dual and single chamber rate adaptive pacemakers.
